From July 1, 2023 to September 14, 2023, the company has repurchased 261,000 shares, representing 0.06% for CNY 5.03 million. With this, the company has completed the repurchase of 1,426,700 shares, representing 0.33% for CNY 30.03 million under the buyback announced on April 25, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.35 CNY | -18.75% | -.--% | -45.40% |
05-06 | Hainan Poly Pharm Gets GMP Certificate From Saudi Authorities | MT |
04-08 | Hainan Poly Pharm Gets Nod to Market Voriconazole Injection in Sweden | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-45.40% | 768M | |
+32.95% | 700B | |
+26.51% | 569B | |
-4.97% | 358B | |
+18.83% | 330B | |
+3.54% | 287B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+6.70% | 161B |
- Stock Market
- Equities
- 300630 Stock
- News Hainan Poly Pharm. Co., Ltd
- Tranche Update on Hainan Poly Pharm. Co., Ltd's Equity Buyback Plan announced on April 25, 2023.